Kothari Products (KOTHARIPRO)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Deep value: P/B of 0.43 implies a 57% discount to book value
• Conservative leverage: Debt/Equity of 0.22 provides a cushion
• High promoter holding of 74.99% aligns interests with minority shareholders
• Latest quarter remains profitable: ₹10 Cr net profit on ₹162 Cr sales

Concerns

• Negative ROCE of -4.68% and low ROE of 5.76% indicate poor capital productivity
• Sales down 26.9% and profit down 105.1% show severe operating deterioration
• Piotroski F-Score of 2/9 points to weak financial health and possible distress signals
• No dividend means shareholders depend entirely on asset realisation or price appreciation

AI Analysis

Kothari Products is a business I can understand on the surface—trading and distribution—but that simplicity cuts both ways. A trader has little pricing power, no brand moat, and lives on thin margins. The numbers confirm this. Sales have fallen 26.9%, and profit is down 105.1%. Return on equity is just 5.76%, and return on capital employed is negative at -4.68%. These are not the economics of a wonderful business. The Piotroski F-Score of 2/9 is a clear red flag: it says the company's financial health has deteriorated, not improved. Yet the balance sheet demands attention. The stock trades at ₹73.04 against book value of ₹170.53—only 0.43 times book. Mr. Market is offering a rupee of net assets for 43 paise. Debt/equity is a conservative 0.22, and promoters hold 74.99%, so their interests are tied to mine. The latest quarter shows a positive net profit of ₹10 Cr on sales of ₹162 Cr, so the business is not dead. But Benjamin Graham taught me that a low price-to-book is only a starting point. The real question is whether the book value is real and productive. With negative ROCE and shrinking sales, I worry that some of that book value may be tied up in non-earning assets or working capital that could erode further. No dividend means I am dependent on management unlocking value. At this price, I would call it an asset play rather than a compounder: potential upside exists if assets are worth their stated value and returns improve, but a value trap if earnings keep falling. I would not rush in without examining the quality of inventory, receivables, and any investments on the books. Price is cheap; the evidence of business quality is not yet there.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer